≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat
    ≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat

    Research use only · Not for human or veterinary use

    Research Compounds
    11/12/2026

    How to Read a Peptide Mass Spec Report

    A plain-language guide to reading a peptide mass spectrometry report: observed versus theoretical mass, charge states, common adducts, and acceptable mass error, kept separate from HPLC purity data.

    Reviewed by Alpha Carbon Labs Research TeamLast updated November 12, 2026

    A peptide mass spectrometry report tells you whether the molecule in a sample has the molecular mass expected for the intended sequence, which an HPLC purity chromatogram cannot show on its own. To read it, compare the observed mass with the theoretical mass, check the charge states and adduct peaks, and confirm that the mass error falls within the tolerance appropriate to the instrument. HPLC answers "how much of the UV signal is one main component"; mass spectrometry answers "is that component the right molecule."

    What does a peptide mass spectrometry report tell you that HPLC does not?

    Mass spectrometry (MS) measures the mass-to-charge ratio (m/z) of ionized molecules, so it provides direct evidence of molecular identity. An HPLC chromatogram separates components and reports relative peak area. A single HPLC peak at 99% area could still be the wrong peptide, because retention time alone does not establish what a molecule is.

    The reverse is also true. A mass spectrum is a poor purity measurement, because different molecules ionize with very different efficiencies. A small impurity can produce a large MS signal, and a major component can ionize weakly. For that reason, the two documents answer separate questions and should be read separately. The HPLC side is covered in our guide on how to read a peptide HPLC test report.

    QuestionHPLC purity chromatogramMass spectrometry identity report
    Is the main component the intended molecule?Not by itselfYes, at the level of molecular mass
    What fraction of UV-detected material is the main peak?Yes (area %)No; ion intensity is not quantitative across species
    Can it detect a missing residue or extra modification?Only if the variant separates as a distinct peakYes, as a predictable mass shift
    Can it distinguish isomers (e.g., Leu vs Ile, D vs L residues)?Sometimes, if they separateNo; isomers share the same mass
    Does it report peptide content by weight?NoNo

    Which fields should a peptide MS report contain?

    A usable MS identity report should state the expected (theoretical) mass, the observed mass, the ionization method, the ion polarity, the instrument type, and the lot or batch number of the sample. Without these fields, the observed number cannot be checked against anything.

    Look for the following items, typically on a page attached to the certificate of analysis. Example certificates can be reviewed on our CoA documents page.

    • Sequence and molecular formula of the intended peptide, including terminal groups and any modifications.
    • Theoretical mass, labeled as monoisotopic or average.
    • Ionization method: electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI).
    • Polarity: positive mode (protonated ions, [M+H]+) or negative mode (deprotonated ions, [M−H]−).
    • The raw spectrum, with labeled peaks, not just a single number.
    • Observed m/z values and, for ESI, the deconvolved neutral mass.
    • Mass error, in daltons (Da) or parts per million (ppm), and the acceptance criterion used.

    Monoisotopic or average mass: which one is being compared?

    The monoisotopic mass uses only the most abundant isotope of each element (for example, carbon-12). The average mass weights every isotope by natural abundance. A report must compare like with like; mixing the two conventions creates an apparent error that is not real.

    For a peptide near 2,000 Da, the average mass is roughly one dalton higher than the monoisotopic mass, and the gap grows with size. High-resolution instruments resolve individual isotope peaks, so they usually report monoisotopic values. Lower-resolution instruments, or analyses of larger peptides where the monoisotopic peak is small, often report average mass. Senko and colleagues described methods for assigning monoisotopic masses from resolved isotope distributions of large biomolecules, which illustrates why the choice matters as size increases.

    A related trap is the salt form. A product page or label may list the molecular weight of an acetate or trifluoroacetate (TFA) salt, but MS observes the peptide ion itself. The theoretical value on the MS page should be the free peptide, not the salt.

    Why does one peptide produce several peaks?

    Electrospray ionization typically adds several protons to a peptide, producing a series of ions such as [M+2H]2+, [M+3H]3+ and [M+4H]4+. Each appears at a different m/z, so a single peptide yields a family of peaks. This multiple charging was central to the original description of ESI for large biomolecules by Fenn and coworkers.

    The relationship is simple. For a neutral monoisotopic mass M and charge z, the expected positive-mode peak is m/z = (M + z × 1.00728) / z, where 1.00728 Da is the mass of a proton. Using a hypothetical peptide with M = 2,000.000 Da:

    • [M+H]+ appears at m/z 2001.007
    • [M+2H]2+ appears at m/z 1001.007
    • [M+3H]3+ appears at m/z 667.674

    Software then "deconvolutes" the series back to one neutral mass. A report that shows only a deconvolved number hides the evidence; the raw charge-state series is what lets a reader confirm the assignment. Mann, Meng and Fenn described the mathematics of interpreting these multiply charged ion series.

    How can you tell the charge state of a peak?

    On high-resolution spectra, look at the spacing between isotope peaks. Carbon-13 adds about 1.003 Da, so isotope peaks sit about 1.003/z apart on the m/z axis. Spacing of about 0.50 indicates a 2+ ion; about 0.33 indicates 3+. MALDI spectra, by contrast, are dominated by singly charged [M+H]+ ions, which makes them simpler to read but less informative about charge.

    What are common adducts on a peptide mass spec report?

    Adducts are ions in which something other than, or in addition to, a proton is attached to the peptide. Sodium and potassium are the most common, coming from glassware, buffers and solvents. They appear as satellite peaks at predictable offsets from the protonated ion and usually do not indicate a problem with the peptide itself.

    Ion speciesMass added to neutral M (Da)Offset from [M+H]+ at 1+Typical origin
    [M+H]++1.0073referenceProtonation (expected)
    [M+NH4]++18.0338+17.03Ammonium buffers
    [M+Na]++22.9892+21.98Glassware, salts, solvents
    [M+K]++38.9632+37.96Glassware, salts, handling
    [M−H]− (negative mode)−1.0073n/aDeprotonation (expected)
    [M+TFA−H]− (negative mode)+112.9856n/aTrifluoroacetate counter-ion

    On multiply charged ions the offsets shrink by the charge. Replacing one proton with sodium on a 2+ ion shifts the peak by about +10.99 m/z; on a 3+ ion, by about +7.33 m/z. For the hypothetical 2,000 Da peptide, [M+H+Na]2+ appears near m/z 1011.998, next to [M+2H]2+ at 1001.007. Keller and colleagues catalogued these and many other background ions encountered in modern MS laboratories.

    Do adducts mean the sample is impure?

    Not usually. Small sodium or potassium peaks are expected in ESI and MALDI spectra. They become worth noting when they dominate the spectrum, when an unexplained mass offset appears that does not match any common adduct, or when the report does not label them at all. TFA can also suppress ESI signal, which is one reason some laboratories avoid it in LC-MS mobile phases.

    Which mass shifts suggest a modification or impurity?

    Peaks offset by amounts that do not match common adducts often correspond to chemical changes in the peptide. Many have well-documented mass shifts, which are compiled in resources such as the Unimod database described by Creasy and Cottrell. Recognizing them is one of the main reasons to request the full spectrum.

    Observed shift (neutral mass)Likely interpretationNotes
    +15.995 DaOxidation (often Met or Trp)Can occur during storage or in the ion source
    +0.984 DaDeamidation (Asn or Gln)Needs high resolution; overlaps isotope peaks
    −0.984 DaC-terminal amide instead of free acid (or vice versa)Check which terminus the sequence specifies
    −18.011 DaLoss of waterMay be an in-source artifact or a cyclized impurity
    −2.016 DaDisulfide bond formationExpected if the peptide is meant to be cyclized
    Mass of one residue (e.g., −57.021 Da for Gly)Deletion sequenceClassic solid-phase synthesis impurity
    Mass of one residue addedInsertion sequenceAlso synthesis-related

    D'Hondt and colleagues reviewed these synthesis- and degradation-related impurities in peptide products, including deletion, insertion, oxidation and deamidation variants. The amide versus acid case is easy to miss because the shift is under one dalton; terminal chemistry is discussed further in our article on amidated peptides and free acids. Background on how sequences are assembled is available on our peptide synthesis page.

    What is an acceptable mass error for peptide identity confirmation?

    Acceptable mass error depends on the instrument. High-resolution accurate-mass instruments (Orbitrap, time-of-flight with calibration, FT-ICR) commonly report agreement within a few parts per million. Lower-resolution instruments, such as single quadrupoles or linear-mode MALDI, are usually judged in daltons or as a small percentage of the mass.

    Mass error in ppm is calculated as (observed − theoretical) / theoretical × 1,000,000. For the hypothetical [M+H]+ ion at 2001.0073, an observed value of 2001.0121 gives an error of about 2.4 ppm. The same 0.0048 Da difference would be meaningless on a low-resolution instrument, whose tolerance might be several tenths of a dalton. Brenton and Godfrey set out the terminology and data treatment for accurate mass measurement, including how mass error and resolution should be expressed.

    • High-resolution, monoisotopic comparisons: errors are typically stated in ppm, often single digits.
    • Low-resolution or average-mass comparisons: errors are typically stated in Da, often within a fraction of a dalton to about one dalton for small peptides.
    • Larger peptides: absolute error in Da naturally grows with mass, so ppm is the fairer comparison when the data support it.

    These ranges are conventions, not universal standards. The meaningful check is whether the report states its own acceptance criterion, and whether the observed error falls inside it. Our quality control page describes how specifications are documented.

    Can a peptide pass on mass and still be wrong?

    Yes. A mass match confirms elemental composition within tolerance, not sequence order or stereochemistry. Scrambled sequences, leucine-for-isoleucine swaps and D- versus L-amino acid substitutions all share the same mass. Confirming sequence requires fragmentation (MS/MS) data or orthogonal methods; an intact-mass report alone cannot rule these out.

    How do larger or modified peptides change the report?

    Larger peptides spread their signal across more charge states, and their monoisotopic peak becomes less intense relative to the isotope envelope. Lipidated or heavily modified sequences, such as semaglutide, which carries a fatty-acid side chain, usually appear in ESI as several multiply charged ions rather than a single dominant peak.

    For such molecules, a reader should expect a deconvolved neutral mass, a clearly stated mass convention, and an annotated raw spectrum showing at least two or three charge states that agree with each other. Smaller sequences, such as BPC-157 at roughly 1.4 kDa, often show a strong [M+2H]2+ ion in ESI and a dominant [M+H]+ ion in MALDI. Identity-focused characterization for one larger sequence is discussed in our article on retatrutide purity assessment.

    A step-by-step checklist for reading the MS page

    1. Match the lot or batch number on the MS page to the vial and the HPLC report.
    2. Confirm the sequence, terminal groups and modifications used to calculate the theoretical mass.
    3. Check whether the theoretical and observed values are both monoisotopic or both average.
    4. Confirm the theoretical value refers to the free peptide, not a salt form.
    5. Identify the main ion species and charge states, and verify they deconvolute to the same neutral mass.
    6. Label satellite peaks as adducts (Na, K, NH4, TFA) or as possible modifications.
    7. Calculate the mass error yourself and compare it with the stated acceptance criterion.
    8. Note what intact mass cannot establish: purity, peptide content, sequence order and stereochemistry.

    Key takeaways

    • MS confirms molecular identity by mass; HPLC estimates relative chromatographic purity. Neither replaces the other.
    • ESI produces multiple charge states, and the raw series should agree after deconvolution.
    • Sodium, potassium, ammonium and TFA adducts appear at predictable offsets and are usually not impurities.
    • Unexplained offsets such as +16, −18 or the mass of one residue point to oxidation, water loss or deletion sequences.
    • Mass error should be expressed in ppm or Da according to instrument resolution and compared with a stated criterion.
    • A correct mass does not prove correct sequence order or stereochemistry.

    Frequently Asked Questions

    Why is the observed mass slightly different from the theoretical mass?

    Every mass spectrometer has finite accuracy, so a small difference is expected. The question is whether the difference falls within the instrument's stated tolerance. A larger mismatch near one dalton for a small peptide often reflects a convention mix-up between monoisotopic and average mass, or an amide versus free-acid terminus, rather than a different molecule.

    What does [M+2H]2+ mean on a peptide report?

    It denotes the intact peptide (M) carrying two extra protons, giving it a 2+ charge. Because the mass spectrometer measures mass divided by charge, this ion appears at roughly half the peptide's mass plus one. Seeing it alongside [M+3H]3+ and other charge states, all pointing to the same neutral mass, strengthens the identity assignment.

    Is a sodium adduct peak a sign of contamination?

    Generally not. Sodium is ubiquitous in glassware, solvents and salts, and small [M+Na]+ or [M+H+Na]2+ peaks are routine in electrospray and MALDI spectra. They sit about 22 Da above the protonated ion at 1+, or about 11 m/z at 2+. A sodium peak becomes notable only if it dominates the spectrum or is left unlabeled.

    Can mass spectrometry measure peptide purity?

    Not reliably on its own. Different molecules ionize with different efficiencies, so peak intensity in a mass spectrum does not track relative amount. Purity is normally estimated by HPLC with UV detection, while MS confirms which molecule each peak represents. LC-MS links the two, but the purity figure still comes from the calibrated chromatographic detector.

    What mass error is acceptable on a high-resolution instrument?

    High-resolution accurate-mass instruments are commonly expected to agree with theoretical monoisotopic values within a few parts per million when properly calibrated. The exact limit varies by laboratory and method. The more useful check is whether the report states its own acceptance criterion in ppm or daltons and whether the calculated error falls inside it.

    Why does the MS report show a different molecular weight than the label?

    Labels often state the molecular weight of a salt form, such as an acetate or trifluoroacetate salt, or use average mass. The MS page should report the free peptide's mass, often monoisotopic. Comparing a salt-form average molecular weight with an observed monoisotopic ion will produce a discrepancy that does not reflect the identity of the peptide.

    Limitations

    This article summarizes published analytical chemistry literature and general mass spectrometry conventions for interpreting identity data. Acceptance criteria and instrument performance vary between laboratories, and the worked numbers use a hypothetical peptide for illustration. Nothing here establishes the safety, effectiveness, regulatory approval, or suitability of any material sold by Alpha Carbon Labs for human or veterinary use; all materials are intended solely for nonclinical laboratory research.

    References

    1. 1. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64-71.
    2. 2. Mann M, Meng CK, Fenn JB. Interpreting mass spectra of multiply charged ions. Analytical Chemistry. 1989;61(15):1702-1708.
    3. 3. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Analytical Chemistry. 1988;60(20):2299-2301.
    4. 4. Brenton AG, Godfrey AR. Accurate mass measurement: terminology and treatment of data. Journal of the American Society for Mass Spectrometry. 2010;21(11):1821-1835.
    5. 5. Keller BO, Sui J, Young AB, Whittal RM. Interferences and contaminants encountered in modern mass spectrometry. Analytica Chimica Acta. 2008;627(1):71-81.
    6. 6. Senko MW, Beu SC, McLafferty FW. Determination of monoisotopic masses and ion populations for large biomolecules from resolved isotopic distributions. Journal of the American Society for Mass Spectrometry. 1995;6(4):229-233.
    7. 7. Kebarle P, Verkerk UH. Electrospray: from ions in solution to ions in the gas phase, what we know now. Mass Spectrometry Reviews. 2009;28(6):898-917.
    8. 8. D'Hondt M, Bracke N, Taevernier L, Gevaert B, Verbeke F, Wynendaele E, De Spiegeleer B. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis. 2014;101:2-30.
    9. 9. Creasy DM, Cottrell JS. Unimod: Protein modifications for mass spectrometry. Proteomics. 2004;4(6):1534-1536.
    10. 10. Zhang Z, Marshall AG. A universal algorithm for fast and automated charge state deconvolution of electrospray mass-to-charge ratio spectra. Journal of the American Society for Mass Spectrometry. 1998;9(3):225-233.

    All research information is for educational purposes only. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.